-
India's National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 56 formulations and also capped the ceiling prices of two formulations, reported The Economic Times.
-
The formulations include treatments for various diseases, including cardiac conditions, anxiety disorders, hepatitis C and diabetes.
-
Specifically, some of the drugs include sofosbuvir and ledipasvir used for treatment of hepatitis C.
-
The NPPA has also fixed the retail price of teneligliptin metformin used for the treatment of diabetes, and capped the ceiling prices of digoxin and furosemide oral liquids.
-
FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>
To read more NewsPoints articles, click here.
